Regulated information

Get easy access to all the information you need. The documentation center allows you to open, send by e-mail or download any document. Feel free to use the filters and add several documents to your basket.

21 publications

Name	Date	Type
2020 annual results 2020 sales: €427.5m (up 8.0% as reported) EBIT before depreciation of assets arising from acquisitions: €65.3m (up 33.5%) Net income - Group share: €19.2m (4.5% of sales) Cash flow: €92.2m	01/04/2021	Public releases
2020 sales: €427.5M (up 8.0% as reported, up 10.9% at constant exchange rate) essentials sales: €220.6M (up 15.7% as reported, up 17.3% at constant exchange rate) Vetoquinol CEO Matthieu Frechin said: “2020 was an exceptional year on a number of counts. Above all, it is important to pay tribute to our teams, whose hard work and exemplary dedication allowed us to manage the impact of the health crisis. Year on year, we achieved double-digit sales growth at constant exchange rates, driven by our Essentials products. This momentum accounts for additional sales of €43 million (at constant exchange rates). We also completed a major acquisition in the form of the Drontal® and Profender® product ranges, entailing three structural effects for Vetoquinol: a scale effect, a product mix effect in the Essentials range and potential extensions, the first of which has been confirmed in January 2021 for the Australian market. We are optimistic for our business outlook in 2021, while being vigilant in relation to the global sanitary situation.”	21/01/2021	Public releases
2021 first half results 2021 Half year results	29/07/2021	Public releases
Availability of the 2020 universal registration document Vetoquinol informs that it has filed its 2020 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 28th, 2021.	28/04/2021	Public releases
Orion Animal Health and Vetoquinol expand collaboration - Vetoquinol to distribute Orion’s Clevor® in the USA and Orion to distribute Drontal® and Profender® products in Finland, Hungary and Romania Orion Animal Health and Vetoquinol are expanding their collaboration with new distribution agreements.	18/01/2021	Public releases
Programme de rachat - April 2021	05/05/2021	Monthly communication regarding buyback programs
Programme de rachat - August 2021 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres	06/09/2021	Monthly communication regarding buyback programs
Programme de rachat - December 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres	07/01/2021	Monthly communication regarding buyback programs
Programme de rachat - February 2021 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres	05/03/2021	Monthly communication regarding buyback programs
Programme de rachat - January 2021 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres	04/02/2021	Monthly communication regarding buyback programs